Formulation Development and in-vitro Evaluation of Escitalopram Fast Dissolving Tablets.

Vishal BhatiaAshwani K DhingraRameshwar DassBhawna ChopraKumar Guarve

Published in: Central nervous system agents in medicinal chemistry (2022)

As a result, after confirming in-vivo potential, the created fast release formulation exhibited impressive in-vitro findings and may prove to be a boon in treating acute depression attacks.

Keyphrases

drug delivery
liver failure
respiratory failure
depressive symptoms
major depressive disorder
drug induced
sleep quality
aortic dissection
hepatitis b virus
physical activity
extracorporeal membrane oxygenation
bipolar disorder
acute respiratory distress syndrome